A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Items 201–300 of 912
Postresuscitation care: entering a new era
Nolan, J. P., & Soar, J. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283383dca · Cited by 42
Matsushima, K., Peng, M., Velasco, C., Schaefer, É., Diaz-Arrastia, R. R., & Frankel, H. L. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.08.012 · Cited by 72
“These cut points for range of target glucose level were determined based on reported data before conducting the study [12-19].”
BackgroundMethodHanazaki, K., Kitagawa, H., Yatabe, T., Munekage, M., Dabanaka, K., Takezaki, Y., Tsukamoto, Y., Asano, T., Kinoshita, Y., & Namikawa, T. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.07.048 · Cited by 44
Jiang, J., Li, S., Zhao, Y., Zhou, Z., Zhang, J., Sun, R., & Luo, A. (2021) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2021.110504 · Cited by 43
Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes
Dendy, J. A., Chockalingam, V., Tirumalasetty, N. N., Dornelles, A., Blonde, L., Bolton, P. M., Meadows, R. Y., & Andrews, S. S. (2014) · Endocrine Practice · doi:10.4158/ep13467.or · Cited by 41
Krinsley, J. S., Bruns, D. E., & Boyd, J. C. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814566507 · Cited by 41
Sabatino, A., Fiaccadori, E., Barazzoni, R., Carrero, J. J., Cupisti, A., De Waele, E., Jonckheer, J., Cuerda, C., & Bischoff, S. C. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.08.002 · Cited by 40
Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?
Schwartz, S. S., & DeFronzo, R. A. (2013) · Diabetes Care · doi:10.2337/dc12-2060 · Cited by 45
“However, most studies in ICU patients have failed to demonstrate any benefit on mortality with intensive insulin therapy (10– 12), and two large randomized trials (13,14) with insulin in ICU patients were stopped prematurely because of increased hypoglycemia and lack of benefit.”
BackgroundBarriers and facilitators to the use of computer-based intensive insulin therapy
Campion, T. R., Waitman, L. R., Lorenzi, N. M., May, A. K., & Gadd, C. S. (2011) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2011.10.003 · Cited by 38
“Intensive insulin therapy (IIT) is the standard of critical care, but recent studies raise questions about the therapy’s mortality benefit and risk to patients [1-4].”
Critical Care Management of Stress-Induced Hyperglycemia
Vanhorebeek, I., Gunst, J., & den Berghe, G. V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0988-2 · Cited by 43
Glycemic control in the critically ill: What have we learned since NICE-SUGAR?
Krinsley, J. S. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1066227 · Cited by 43
“Only one of these reported percentage of time in the defined target [4].”
van Hooijdonk, R. T. M., Leopold, J. H., Winters, T., Binnekade, J. M., Juffermans, N. P., Horn, J., Fischer, J., van Dongen-Lases, E. C., & Schultz, M. J. (2015) · Critical Care · doi:10.1186/s13054-015-0757-4 · Cited by 46
“Continuous glucose monitoring (CGM) is suggested to increase practicalities and safety of insulin titration in ICU patients [1,4], in particular when targeting normal or near-normal blood glucose levels when hypoglycemic episodes can be expected [5-13].”
BackgroundFeasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants
Beardsall, K., Thomson, L. M., Elleri, D., Dunger, D. B., & Hovorka, R. (2019) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2019-316871 · Cited by 39
Hyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes
Becker, C. D., Sabang, R. L., Cordeiro, M. F. N., Hassan, I. F., Goldberg, M. D., & Scurlock, C. S. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.012 · Cited by 43
A guideline for the use of variable rate intravenous insulin infusion in medical inpatients
George, S., Dale, J., Stanisstreet, D., & Care, T. J. B. D. S. (. F. I. (2015) · Diabetic Medicine · doi:10.1111/dme.12756 · Cited by 40
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Steil, G. M., Langer, M., Jaeger, K., Alexander, J. L., Gaies, M., & Agus, M. S. D. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e31821926a5 · Cited by 38
“8%) (6), both of which were stopped over concerns related to hypoglycemia.”
BackgroundManagement of Hyperglycemia During the Perioperative Period
Pichardo-Lowden, A. R., & Gabbay, R. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0239-2 · Cited by 39
Is it time to abandon glucose control in critically ill adult patients?
Krinsley, J. S., & Preiser, J. (2019) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000621 · Cited by 40
Self-citationSaur, N. M., Kongable, G. L., Holewinski, S., O’Brien, K., & Nasraway, S. A. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.07.003 · Cited by 37
Tight glucose control in critically ill children - a systematic review and meta-analysis
Srinivasan, V., & Agus, M. S. D. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12134 · Cited by 37
Abdelmalak, B., & Lansang, M. C. (2013) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2012.09.006 · Cited by 41
“mmol/L) [3].”
BackgroundInfluentialOptimal Glucose Management in the Perioperative Period
Evans, C. H., Lee, J., & Ruhlman, M. K. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.11.003 · Cited by 43
“A significant secondary outcome revealed in several studies is tight glucose control by IIT, associated with a 4-fold to 6-fold increase in the incidence of hypoglycemia.(22,23) Guidelines for perioperative glycemic control are limited by the available evidence.”
BackgroundPerioperative glycaemic control for people with diabetes undergoing surgery
Bellon, F., Solà, I., Giménez‐Pérez, G., Hernández, M., Metzendorf, M., Rubinat, E., & Mauricio, D. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007315.pub3 · Cited by 49
Intensive Insulin Therapy in Critically Ill Hospitalized Patients: Making it Safe and Effective
Klonoff, D. C. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500330 · Cited by 39
Dysglycemia in the critically ill patient: current evidence and future perspectives
Aramendi, I., Burghi, G., & Manzanares, W. (2017) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20170054 · Cited by 36
“In contrast, these RCTs showed unacceptable levels of hypoglycemia in some patients,(2,3) and some of them, such as the Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE-SUGAR), showed a significant increase in mortality in patients who received intensive treatment with i…”
BackgroundResultAbnormalities in glucose homeostasis in critically Ill children*
Bhutia, T. D., Lodha, R., & Kabra, S. K. (2012) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182604998 · Cited by 36
Impact of intraoperative hyperglycaemia on renal dysfunction after off-pump coronary artery bypass
Song, J. W., Shim, J., Yoo, K., Oh, S. Y., & Kwak, Y. L. (2013) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivt209 · Cited by 37
Clinical benefits of tight glycaemic control: focus on the intensive care unit
Mesotten, D., & den Berghe, G. V. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.08.006 · Cited by 39
Ackerbroeck, S. V., Schepens, T., Janssens, K., Jorens, P. G., Verbrugghe, W., Collet, S., Hoof, V. O. V., Gaal, L. V., & Block, C. E. M. D. (2015) · Critical Care · doi:10.1186/s13054-015-1064-9 · Cited by 38
“Although strict glycaemic control (80–110 mg/dl) is no longer advocated for most ICUs, there is a consensus that manifest hyperglycaemia should be treated and insulininduced hypoglycaemia should be avoided [7, 10, 11].”
BackgroundZuo, Y.-Y., Kang, Y., Yin, W., Wang, B., & Chen, Y. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.12.004 · Cited by 38
“However, the results of this study have not been replicated in other settings [10-14].”
Resultvan Steen, S. C. J., Rijkenberg, S., Sechterberger, M. K., DeVries, J. H., & van der Voort, P. H. J. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1045 · Cited by 36
Brain Glucose Sensing and the Problem of Relative Hypoglycemia
Schwartz, M. W., Krinsley, J. S., Faber, C. L., Hirsch, I. B., & Brownlee, M. (2023) · Diabetes Care · doi:10.2337/dc22-1445 · Cited by 36
The 2013 Arvid Wretlind lecture: Evolving concepts in parenteral nutrition
Berger, M. M. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.03.005 · Cited by 34
Our Scientific Journey through the Ups and Downs of Blood Glucose Control in the ICU
den Berghe, G. V., Vanhorebeek, I., Langouche, L., & Gunst, J. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202309-1696so · Cited by 35
The flux of energy in critical illness and the obesity paradox
Jaitovich, A., & Hall, J. B. (2025) · Physiological Reviews · doi:10.1152/physrev.00029.2024 · Cited by 37
Block, C. E. M. D., Rogiers, P., Jorens, P. G., Schepens, T., Scuffi, C., & Gaal, L. F. V. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0214-9 · Cited by 34
Hyperglycaemia in critically ill patients: the immune system’s sweet tooth
van Niekerk, G., Davis, T., & Engelbrecht, A. (2017) · Critical Care · doi:10.1186/s13054-017-1775-1 · Cited by 38
Continuous Measurement of Blood Glucose: Validation of a New Intravascular Sensor
Skjærvold, N. K., Solligård, E., Hjelme, D. R., & Aadahl, P. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ff4187 · Cited by 34
Pérez-Calatayud, Á. A., Guillén-Vidaña, A., Fraire-Félix, I. S., Malagón, E. D. A., Garduño, J. C. B., & Carrillo-Esper, R. (2016) · Cirugía y Cirujanos · doi:10.1016/j.circir.2016.10.026 · Cited by 33
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00671-6 · Cited by 37
Krinsley, J. S., Rule, P. R., Roberts, G. W., Brownlee, M., Preiser, J., Chaudry, S., Dionne, K. D., Heluey, C., Umpierrez, G. E., & Hirsch, I. B. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005490 · Cited by 34
“The GLUCONTROL trial was the only RCT that reported TIR, though these data were not stratified by diabetes status (29).”
BackgroundSelf-citationManagement of critically ill patients with type 2 diabetes: The need for personalised therapy
Kar, P., Jones, K. L., Horowitz, M., & Deane, A. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i5.693 · Cited by 37
The Place for Glycemic Control in the Surgical Patient
May, A. K., Kauffmann, R. M., & Collier, B. R. (2011) · Surgical Infections · doi:10.1089/sur.2011.019 · Cited by 37
“Studies of glycemic control have been performed in both the peri-operative and ICU settings, although the majority have been studies of both surgical and non-surgical ICU populations [1,6-10,21,72-74], with a smaller number of studies focused specifically on the peri-operative setting, nearly all of which are in the s…”
InfluentialMetabolic Management during Critical Illness: Glycemic Control in the ICU
Inzucchi, S. E., & Honiden, S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1565253 · Cited by 36
“6,8,42 There were no differences in mortality observed between the conventional and the intensively treated groups in either of these studies.”
Sathishkumar, S., Lai, M., Picton, P., Kheterpal, S., Morris, M., Shanks, A. M., & Ramachandran, S. K. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000699 · Cited by 33
The role of hyperglycemia in acute illness: Supporting evidence and its limitations
Corathers, S. D., & Falciglia, M. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.013 · Cited by 37
First pilot trial of the STAR-Liege protocol for tight glycemic control in critically ill patients
Penning, S., Compte, A. J. L., Moorhead, K. T., Desaive, T., Massion, P. B., Preiser, J., Shaw, G. M., & Chase, J. G. (2011) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2011.07.003 · Cited by 33
“[10, 11, 19]), as well as ensuring safety in this proofof-concept pilot trial.”
BackgroundMethodInfluentialSelf-citationDoola, R., Greer, R. M., Hurford, R., Flatley, C. J., Forbes, J. M., Todd, A. S., Joyce, C., & Sturgess, D. J. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.001 · Cited by 36
Westphal, G. A., Filho, M. C., Vieira, K. D., Zaclikevis, V. R., Bartz, M. C. M., Wanzuita, R., Réa-Neto, Á., Teixeira, C., Franke, C. A., Machado, F. O., et al. (2011) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2011000300004 · Cited by 48
Glucose Dysregulation and Neurological Injury Biomarkers in Critically Ill Children
Vanhorebeek, I., Gielen, M., Boussemaere, M., Wouters, P. J., Güiza, F., Mesotten, D., & den Berghe, G. V. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0805 · Cited by 32
Pri, A. S., Chase, J. G., Pretty, C. G., Shaw, G. M., Preiser, J., Vincent, J., Oddo, M., Taccone, F. S., Penning, S., & Desaive, T. (2014) · Critical Care · doi:10.1186/preaccept-4717752591304980 · Cited by 39
Self-citationPreechasuk, L., Suwansaksri, N., Ipichart, N., Vannasaeng, S., Permpikul, C., & Sriwijitkamol, A. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.12.005 · Cited by 33
“Despite this association between sepsis severity and hyperglycemia, studies [3-9] that have aimed to normalize glucose levels have shown inconclusive findings on sepsis outcomes.”
BackgroundInsulin dysregulation in horses with systemic inflammatory response syndrome
Bertin, F., Ruffin‐Taylor, D., & Stewart, A. J. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15138 · Cited by 35
Uyttendaele, V., Knopp, J. L., Stewart, K. W., Desaive, T., Benyó, B. I., Némedi, N. S., Illyés, A., Shaw, G. M., & Chase, J. G. (2018) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2018.05.032 · Cited by 32
Shah, F. A., Mahmud, H., Gallego‐Martin, T., Jurczak, M. J., O'Donnell, C. P., & McVerry, B. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00296 · Cited by 33
Impact of a computer-generated alert system on the quality of tight glycemic control
Meyfroidt, G., Wouters, P. J., Becker, W. D., Cottem, D., & den Berghe, G. V. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2159-7 · Cited by 31
“results [4–9].”
Hsu, C.-W., Sun, S., Lin, S.-L., Huang, H.-H., & Wong, K.-F. (2012) · Critical Care · doi:10.1186/cc11299 · Cited by 31
“However, some studies failed to demonstrate improved outcome [9-12], and even a higher mortality rate was found [13] Intensive insulin therapy has been associated with a significantly higher risk of hypoglycemia [5,7], resulting in concern regarding the safety of intensive insulin therapy.”
ResultRijkenberg, S., van Steen, S. C. J., DeVries, J. H., & van der Voort, P. H. J. (2017) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-017-0086-z · Cited by 31
Uyttendaele, V., Knopp, J. L., Davidson, S. M., Desaive, T., Benyó, B. I., Shaw, G. M., & Chase, J. G. (2019) · BioMedical Engineering OnLine · doi:10.1186/s12938-019-0720-8 · Cited by 31
The Impact of COVID-19 on CGM Use in the Hospital
Ehrhardt, N. M., & Hirsch, I. B. (2020) · Diabetes Care · doi:10.2337/dci20-0046 · Cited by 30
Olveira, G., García‐Luna, P. P., Pereira, J. L. S., Rebollo, I., García‐Almeida, J. M., Serrano, P., Rocamora, J. A. I., Muñoz-Aguilar, A., Molina, M. A. J., & Tapia, M. J. (2012) · PubMed · doi:10.3305/nh.2012.27.6.6076 · Cited by 34
Watkinson, P., Barber, V. S., Amira, E., James, T., Taylor, R. P., & Young, J. D. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011162 · Cited by 32
Evaluation of a Continuous Blood Glucose Monitoring System Using Central Venous Microdialysis
Schierenbeck, F., Franco‐Cereceda, A., & Liška, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600615 · Cited by 34
Insulin therapy in critically ill patients
Ellahham, S. H. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s14203 · Cited by 35
A J-shaped relationship between caloric intake and survival in critically ill patients
Crosara, I. C. R., Mélot, C., & Preiser, J.-C. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0079-3 · Cited by 29
“Preiser JC, Devos P, Ruiz‑Santana S, et al. A prospective randomised multi‑centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study.”
BackgroundMethodSelf-citationSharma, S., Gupta, A., Biswas, A., Sharma, A., Malhotra, A., Prasad, K. T., Vishnubhatla, S., Ajmani, S., Mishra, H. K., Soneja, M., et al. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.192063 · Cited by 29
Perioperative Glycemic Control
Russo, N. (2012) · Anesthesiology Clinics · doi:10.1016/j.anclin.2012.07.007 · Cited by 35
Dickerson, R. N., Hamilton, L. A., Connor, K. A., Maish, G. O., Croce, M. A., Minard, G., & Brown, R. O. (2010) · Nutrition · doi:10.1016/j.nut.2010.08.009 · Cited by 33
“Data extracted from the large intensive insulin therapy trials[2,3,29-31] may indirectly support our observations.”
BackgroundMethodResultDevelopment and current use of parenteral nutrition in critical care – an opinion paper
Berger, M. M., & Pichard, C. (2014) · Critical Care · doi:10.1186/s13054-014-0478-0 · Cited by 39
“Only after the 2001 Leuven trial did the medical community become aware of the importance of controlling blood glucose levels by means of continuous insulin therapy [25], although the NICE SUGAR and Glucontrol trials subsequently demonstrated that intensive insulin therapy was potentially dangerous [26,27] and that le…”
BackgroundRecognizing Hypoglycemia in Children Through Automated Adverse-Event Detection
Dickerman, M. J., Jacobs, B. R., Vinodrao, H., & Stockwell, D. C. (2011) · PEDIATRICS · doi:10.1542/peds.2009-3432 · Cited by 29
The association of age, illness severity, and glycemic status in a pediatric intensive care unit
Ognibene, K. L., Vawdrey, D. K., & BIAGAS, K. V. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182192c53 · Cited by 29
Wang, T. K. M., Woodhead, A., Ramanathan, T., & Pemberton, J. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.05.117 · Cited by 32
“5-6mmol/L) to have no benefit and perhaps increased mortality for patients in intensive care unit compared [49_TD$DIFF]with conventional treatment (target <10mmol/L), probably in part driven by more [50_TD$DIFF]hypoglycaemic events [25,26].”
BackgroundNutrition delivery of a model-based ICU glycaemic control system
Stewart, K. W., Chase, J. G., Pretty, C. G., & Shaw, G. M. (2018) · Annals of Intensive Care · doi:10.1186/s13613-017-0351-9 · Cited by 29
Parenteral nutrition in the ICU: Lessons learned over the past few years
Berger, M. M., & Pichard, C. (2018) · Nutrition · doi:10.1016/j.nut.2018.08.012 · Cited by 31
Glycemic targets in critically ill adults: A mini-review
See, K. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1719 · Cited by 28
Infusion fluids contain harmful glucose degradation products
Bryland, A., Broman, M., Erixon, M., Klarin, B., Lindén, T., Friberg, H., Wieslander, A. P., Kjellstrand, P. T. T., Ronco, C., Carlsson, O., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1873-x · Cited by 27
Amrein, K., Ellmerer, M., Hovorka, R., Kachel, N., Parcz, D., Korsatko, S., Smolle, K., Perl, S., Bock, G., Doll, W., et al. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0147 · Cited by 28
Matias, C. D. N., de Lima, V. C. C., Teixeira, H. M., Souto, F. R., & Magalhães, V. (2013) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20130013 · Cited by 28
“However, a recent large-scale randomized trial indicated that such glycemic control is not effective in reducing ICU mortality and that glycemic control with intensive insulin therapy increases the risk of hypoglycemia and complications arising from hypoglycemia(8).”
ResultRabinovich, M., Grahl, J., Durr, E. A., Gayed, R. M., Chester, K. W., McFarland, R., & McLean, B. A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817747617 · Cited by 28
“Safety concerns have been raised in multiple randomized controlled trials comparing tight glycemic control versus conventional targets regarding the incidence of severe hypoglycemia (BG <40 mg/dL) and its relationship with increased mortality.(5,7-9) Furthermore, numerous retrospective 747617 DSTXXX10.”
BackgroundThe use of GLP‐1 receptor agonists in hospitalised patients: An untapped potential
Mustafa, O. G., & Whyte, M. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3191 · Cited by 27
The goal of personalized glucose control in the critically ill remains elusive
Krinsley, J. S., Deane, A. M., & Gunst, J. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06530-y · Cited by 27
“Indeed, although subsequent single-center RCTs confirmed benefit [2, 3], multicenter RCTs were largely neutral [4], and the NICESUGAR RCT [5] demonstrated increased mortality with tight glucose control, which the investigators attributed to an increased incidence of moderate and severe hypoglycemia [6].”
BackgroundBioinformatics assistance of metabolic and nutrition management in the ICU
Berger, M. M., & Que, Y. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328341ed77 · Cited by 27
Zhou, T., Dickson, J. L., Shaw, G. M., & Chase, J. G. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817738791 · Cited by 26
Eslami, S., Abu–Hanna, A., de Keizer, N. F., Bosman, R. J., Spronk, P. E., de Jonge, E., & Schultz, M. J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1924-3 · Cited by 26
“Although some studies showed that the implementation of GC with insulin came with the risk of hypoglycemia [5, 6, 11–13], others did not [14–18].”
Oghazian, M. B., Javadi, M. R., Radfar, M., Torkamandi, H., Sadeghi, M., Hayatshahi, A., & Gholami, K. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1546 · Cited by 28
Keegan, M. T., Vrchota, J. M., Haala, P. M., & Timm, J. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.05.156 · Cited by 27
Perioperative glycemic management in 2011: paradigm shifts
Maerz, L. L., & Akhtar, S. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328348beb7 · Cited by 32
Inpatient Hypoglycemia: A Challenge That Must Be Addressed
Eiland, L. A., Goldner, W. S., Drincic, A., & Desouza, C. V. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0445-1 · Cited by 27
“Of note, patients in both groups who experienced hypoglycemia had higher mortality rates [7].”
BackgroundMethodInfluentialThe evolution of eProtocols that enable reproducible clinical research and care methods
Blagev, D., Hirshberg, E. L., Sward, K. A., Thompson, B., Brower, R. G., Truwit, J. D., Hite, D., Steingrub, J. S., Orme, J. F., Clemmer, T. P., et al. (2012) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-012-9356-y · Cited by 26
“For example, when new studies regarding glycemic control in the ICU were published, eProtocol-insulin was updated to reflect the new data [36, 37, 39–41].”
Duncan, A. E., Kashy, B. K., Sarwar, S., Singh, A. K., Stenina‐Adognravi, O., Christoffersen, S., Alfirevic, A., Sale, S., Yang, D., Thomas, J. D., et al. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000723 · Cited by 26
The impact of glycaemic variability on the surgical patient
Dhatariya, K., Levy, N., & Hall, G. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000326 · Cited by 31
“6 mmol/l) was associated hypoglycaemia [42].”
BackgroundSaliba, L., Cook, C. H., Dungan, K. M., Porter, K. M., & Murphy, C. V. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.06.010 · Cited by 28
“This is particularly important given the recent interest in the risks of hypoglycemia associated with more aggressive glycemic control [1-6].”
BackgroundOvalle, F. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79602-5 · Cited by 26
A patient-level meta-analysis of intensive glucose control in critically ill adults
Adigbli, D., Li, Y., Hammond, N., Chatoor, R., Devaux, A. G., Li, Q., Billot, L., Annane, D., Arabi, Y., Bilotta, F., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2400082 · Cited by 25
Self-citationClinical challenges of glycemic control in the intensive care unit: A narrative review
Sreedharan, R., Martini, A., Das, G., Aftab, N., Khanna, S. K., & Ruetzler, K. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11260 · Cited by 26
Combes, J., Borot, S., Mougel, F., & Penfornis, A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01311.x · Cited by 26
“In a retrospective analysis of data from a subset of 211 patients included in the ‘Glucontrol’ trial and 393 patients from the Specialized Relative Insulin Nutrition Titration (SPRINT) initiative, Suhaimi et al. [60] showed that glycaemic variability is greater when insulin protocols do not take into account carbohydr…”
BackgroundMethodEvaluating Glycemic Control Algorithms by Computer Simulations
Wilinska, M. E., Bláha, J., Chassin, L. J., Cordingley, J. J., Dormand, N. C., Ellmerer, M., Haluzík, M., Plank, J., Vlasselaers, D., Wouters, P. J., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0016 · Cited by 25
The impact of hypoglycaemia on patients admitted to hospital with medical emergencies
Tan, H. K., & Flanagan, D. (2013) · Diabetic Medicine · doi:10.1111/dme.12123 · Cited by 27
Simpson, F., Sweetman, E. A., & Doig, G. S. (2010) · Trials · doi:10.1186/1745-6215-11-17 · Cited by 23
“Excessive protocol violations may result in safety issues that can cause multicentre clinical trials to be stopped prematurely [8].”
Background
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.